Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPY19L4 pseudogene 2 (DPY19L4P2) is a pseudogene derived from duplication and subsequent inactivation—by mutations including premature stop codons—of the transmembrane protein-encoding DPY19L4 gene, a member of the DPY19L family[1][3]. Pseudogenes like DPY19L4P2 do not encode functional proteins and are not involved in typical biological or disease pathways. They may persist in the genome as evolutionary remnants, and while some pseudogenes can have regulatory RNA roles affecting gene expression, there is no established functional or disease relevance for DPY19L4P2[1][3][7].
None; drugs do not target pseudogenes such as DPY19L4P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPY19L4 pseudogene 2 (DPY19L4P2).